BMP190
Generic Name: amoxicillin/clavulanate
Pill imprint BMP190 has been identified as Augmentin 250 mg / 62.5 mg.
Augmentin is used in the treatment of urinary tract infection; upper respiratory tract infection; bronchitis; sinusitis; bacterial infection (and more), and belongs to the drug class beta-lactamase inhibitors. There is no proven risk in humans during pregnancy.
Augmentin 250 mg / 62.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Augmentin Images
- Generic Name:
- amoxicillin/clavulanate
- Imprint:
-
BMP190
- Strength:
- 250 mg / 62.5 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Beta-lactamase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00029-6074
More Augmentin resources
- Augmentin
- Augmentin (Wolters Kluwer)
- Augmentin Chewable Tablets (Wolters Kluwer)
- Augmentin Suspension (Wolters Kluwer)
- Augmentin (Cerner Multum)
- Augmentin (Micromedex) - Includes Dosage Information
- Augmentin (FDA)
- Augmentin Chewable (FDA)
- Augmentin Oral Suspension (FDA)


